Boundless Bio

See you @ #AACR25! Boundless co-founder Paul Mischel will help kick off the meeting during the opening plenary, sharing insights on #ecDNA in cancer & Rona Yaeger, a GI oncologist @MSKCancerCenter, will share research on BBI-825, an oral RNR inhibitor. abstractsonline.com/pp8/#!/20273/p…

You can find us this week at #BiocomGPIC! Boundless CEO @ZacharyHornby takes the stage Thursday morning at 11:15 AM to provide insights on the biotech IPO journey. Don’t miss this panel to hear first-hand about the path to going public.

Boundless Bio's Chief Executive Officer, @ZacharyHornby will be at @Piper_Sandler's 36th Annual Healthcare Conference in New York, NY the first week of December for a fireside chat and Q&A. Don't miss the discussion and read more: investors.boundlessbio.com/news-releases/…

Three #ecDNA publications in Nature today - congrats @mischellab and @HowardYChang! One key paper highlights the importance of CHK1, a critical therapeutic vulnerability in ecDNA cancer, and the biological target of our lead program, BBI-355. More here: nature.com/articles/s4158…

You can catch Boundless Bio next week at the inaugural Guggenheim Healthcare Conference in Boston, MA! Our President and Chief Executive Officer,
@ZacharyHornby, will be in attendance to take part in a fireside chat. Join us and learn more: investors.boundlessbio.com/news-releases/…